Other OTC - Delayed Quote • USD
Braxia Scientific Corp. (BRAXF)
At close: April 25 at 3:25 PM EDT
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Roger S. McIntyre | Chairman & CEO | 218.82k | -- | -- |
| Mr. Peter Rizakos | CFO & Director | 127.64k | -- | -- |
Braxia Scientific Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. The company is headquartered in Toronto, Ontario.
Corporate Governance
Braxia Scientific Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
Jul 22, 2024 - Jul 26, 2024
Braxia Scientific Corp. Earnings Call
Related Tickers
26CA.BE ImmunityBio Inc
4.7360
+1.11%
26CA.MU ImmunityBio Inc
5.15
+0.04%
HAVLF HAVN Life Sciences Inc.
0.0112
0.00%
XRTX.V XORTX Therapeutics Inc.
3.6200
-8.35%
PMN ProMIS Neurosciences, Inc.
1.9500
-2.99%
KTTA Pasithea Therapeutics Corp.
7.24
+3.43%
APS.TO Aptose Biosciences Inc.
1.6200
-2.41%
PHRRF PharmaTher Holdings Ltd.
0.1800
+7.78%
EVAX Evaxion Biotech A/S
4.1200
-0.24%
SCPX Scorpius Holdings, Inc.
0.1633
+1.55%